Video

Dr. Kumar on Defining Multiple Myeloma

Shaji Kumar, MD, professor of Medicine, Mayo Clinic, gives an overview on the expanded definition of multiple myeloma.

Shaji Kumar, MD, professor of Medicine, Mayo Clinic, gives an overview on the expanded definition of multiple myeloma.

Multiple myeloma that requires treatment, Kumar explains, is when organ damage such as high calcium, bone disease, anemia, and/or kidney issues occur. However, the definition of multiple myeloma has been expanded to include biomarkers that predict for development of these characteristics. It has also been expanded to include patients who have more than 60% of plasma cells in their bone marrow, have a free light chain ratio of more than 100, or have one or more lesions found on MRI or PET scans.

Researchers have determined that among patients who harbor one of these characteristics, the risk of having symptomatic or active multiple myeloma in 2 years is over 80%. Thus, it may be more beneficial to treat these patients earlier, Kumar says.

Related Videos
Grzegorz S. Nowakowski, MD, and Samuel Yamshon, MD, break down the current treatment landscape for relapsed/refractory follicular lymphoma.
Sagar D. Sardesai, MBBS
Ashkan Emadi, MD, PhD
Matthew J. Baker, PhD
Manmeet Ahluwalia, MD, MBA, FASCO
John Mascarenhas, MD
Javier Pinilla, MD, PhD, and Talha Badar, MBBS, MD, discuss factors that influence later-line treatment choices in chronic myeloid leukemia.
Javier Pinilla, MD, PhD, and Talha Badar, MBBS, MD, on the implications of the FDA approval of asciminib in newly diagnosed CP-CML.
Ritu Salani, MD